CHRONIC MYELOID LEUKEMIA (CML)
Clinical trials for CHRONIC MYELOID LEUKEMIA (CML) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOID LEUKEMIA (CML) trials appear
Sign up with your email to follow new studies for CHRONIC MYELOID LEUKEMIA (CML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Stanford tests bold move: stop rejection drug early after transplant
Disease control Not yet recruitingThis study aims to see if it's safe and possible to stop a key anti-rejection medication (tacrolimus) much earlier than usual after a bone marrow transplant. It will involve 50 adults with various blood cancers who receive a transplant from a matched donor. The goal is to reduce …
Matched conditions: CHRONIC MYELOID LEUKEMIA (CML)
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Mar 06, 2026 15:37 UTC
-
New test could spot hidden leukemia mutations sooner
Diagnosis Not yet recruitingThis study aims to see if a new, highly sensitive blood test (called digital PCR) is as good as the current standard test (NGS) at finding specific mutations that make chronic myeloid leukemia (CML) resistant to certain drugs. It will involve 150 adult CML patients whose current …
Matched conditions: CHRONIC MYELOID LEUKEMIA (CML)
Phase: NA • Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Diagnosis
Last updated Mar 23, 2026 15:16 UTC